{"id":"https://openalex.org/W52430409","doi":null,"title":"[A comparative clinical evaluation of the antidepressive activity of fluoxetine and fluvoxamine].","display_name":"[A comparative clinical evaluation of the antidepressive activity of fluoxetine and fluvoxamine].","alternate_titles":[],"publication_year":1997,"publication_date":"1997-01-01","ids":{"openalex":"https://openalex.org/W52430409","mag":"52430409","pmid":"https://pubmed.ncbi.nlm.nih.gov/9214192"},"language":"ru","primary_location":{"id":"pmid:9214192","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9214192","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova","raw_type":"Comparative Study"},"parent_works":[],"lineage":["https://openalex.org/W52430409"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5058390630","display_name":"Lopukhov Ig","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"I G Lopukhov","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5058390630"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.00646114,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"97","issue":"4","first_page":"53","last_page":"57"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13118","display_name":"Psychological Treatments and Disorders","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fluoxetine","display_name":"fluoxetine","score":1.0},{"id":"https://openalex.org/keywords/fluvoxamine","display_name":"fluvoxamine","score":1.0},{"id":"https://openalex.org/keywords/melancholic-depression","display_name":"endogenous depression","score":0.9990000128746033},{"id":"https://openalex.org/keywords/antidepressant-efficacy","display_name":"antidepressant efficacy","score":0.9210000038146973},{"id":"https://openalex.org/keywords/amitriptyline","display_name":"amitriptyline","score":0.8259999752044678},{"id":"https://openalex.org/keywords/imipramine","display_name":"imipramine","score":0.7749999761581421},{"id":"https://openalex.org/keywords/anxious-depression","display_name":"anxious depression","score":0.7820000052452087},{"id":"https://openalex.org/keywords/stimulant-effects","display_name":"stimulant effects","score":0.5830000042915344},{"id":"https://openalex.org/keywords/sedative-effects","display_name":"sedative effects","score":0.9120000004768372},{"id":"https://openalex.org/keywords/adverse-effects","display_name":"adverse effects","score":0.41600000858306885},{"id":"https://openalex.org/keywords/drug-comparison","display_name":"drug comparison","score":0.5849999785423279}],"concepts":[{"id":"https://openalex.org/C2776134451","wikidata":"https://www.wikidata.org/wiki/Q422244","display_name":"Fluoxetine","level":4,"score":0.9811768531799316},{"id":"https://openalex.org/C2779910183","wikidata":"https://www.wikidata.org/wiki/Q409236","display_name":"Fluvoxamine","level":5,"score":0.870808482170105},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7897654175758362},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.5517477989196777},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5055410861968994},{"id":"https://openalex.org/C102652120","wikidata":"https://www.wikidata.org/wiki/Q2419430","display_name":"Therapeutic effect","level":2,"score":0.4608208239078522},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.36128973960876465},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3122047185897827},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.2395051121711731},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.11835789680480957},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000639","descriptor_name":"Amitriptyline","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000929","descriptor_name":"Antidepressive Agents, Tricyclic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003866","descriptor_name":"Depressive Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D004341","descriptor_name":"Drug Evaluation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005473","descriptor_name":"Fluoxetine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005473","descriptor_name":"Fluoxetine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008376","descriptor_name":"Maprotiline","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016666","descriptor_name":"Fluvoxamine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D016666","descriptor_name":"Fluvoxamine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018687","descriptor_name":"Antidepressive Agents, Second-Generation","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D018687","descriptor_name":"Antidepressive Agents, Second-Generation","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:9214192","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9214192","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova","raw_type":"Comparative Study"},{"id":"mag:52430409","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9214192","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4367339070","https://openalex.org/W2472923799","https://openalex.org/W2403084814","https://openalex.org/W2369662901","https://openalex.org/W1996252533","https://openalex.org/W2358731835","https://openalex.org/W2357086540","https://openalex.org/W4234655151","https://openalex.org/W2170044039"],"abstract_inverted_index":{"Comparative":[0],"study":[1],"of":[2,5,8,32,40,49,63,73,79,82,85,89,99,121,130,145,147,152,163,171],"the":[3,37,77,80,83,106,140,168],"peculiarities":[4,84],"clinical":[6,65,87],"action":[7,88],"fluoxetine":[9,90,115,164],"and":[10,24,52,70,91,104,132,150,165,173],"fluvoxamine":[11],"in":[12,119,139,143],"65":[13],"patients":[14],"with":[15,68,97],"endogenous":[16],"depressions":[17,123],"revealed":[18],"their":[19,94,110],"high":[20],"efficiency":[21],"(in":[22],"74.3%":[23],"64.3%":[25],"respectively).":[26],"Fluoxetine":[27],"was":[28,116,126],"characterised":[29],"by":[30,45],"predominance":[31,69],"a":[33],"stimulating":[34,153],"effect":[35,149,162,170],"from":[36],"first":[38],"days":[39],"treatment":[41,120],"as":[42,44],"well":[43],"relatively":[46,60],"late":[47],"manifestation":[48],"very":[50,117],"thymoleptic":[51,161],"tranquilizing":[53],"impact":[54],"(during":[55],"3-4":[56],"weeks).":[57],"Fluvoxamin":[58],"displayed":[59],"uniform":[61],"occurrence":[62],"separate":[64],"effects":[66,96],"together":[67],"early":[71],"appearance":[72],"antidepressive":[74,101],"influence.":[75],"On":[76],"basis":[78],"comparison":[81],"either":[86],"fluvoxamin":[92,125,166],"or":[93],"side":[95],"those":[98],"traditional":[100],"drugs":[102],"(amitryptilin":[103],"ludiomil)":[105],"preferable":[107],"indications":[108],"for":[109,128],"prescription":[111],"were":[112,137],"determined.":[113],"Thus":[114],"good":[118],"apathetic-adynamic":[122],"while":[124],"recommended":[127],"therapy":[129],"anxious":[131],"melancholic":[133],"depressions.":[134],"Antidepressants":[135],"studied":[136],"ranked":[138],"following":[141],"way":[142],"terms":[144],"decrease":[146],"sedative":[148],"increase":[151],"action:":[154],"amitryptilin,":[155],"fluvoxamin,":[156],"ludiomil,":[157],"fluoxetine.":[158],"The":[159],"proper":[160],"exceeded":[167],"same":[169],"amitryptilin":[172],"ludiomil.":[174]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W52430409","counts_by_year":[],"updated_date":"2026-11-15T12:55:33.944570","created_date":"2016-06-24T00:00:00"}
